by NUNAverse | Dec 8, 2021 | Daily Media Clips
Good Morning NUNAverse, Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron COVID-19 variant, but three doses are able to neutralize it, the companies said in a news release on...
by NUNAverse | Dec 7, 2021 | Daily Media Clips
Good Morning NUNAverse, As the world worries that the Omicron COVID-19 variant may cause a surge of cases and weaken vaccines, drug developers have some encouraging news: Two new COVID-19 pills are coming soon, and are expected to work against all versions of the...
by NUNAverse | Dec 6, 2021 | Daily Media Clips
Good Morning NUNAverse, While at least 12 states have identified cases of the Omicron COVID-19 variant, US health officials remain concerned about the Delta version that accounts for practically all new infections. “We now have about 86,000 cases...
by NUNAverse | Dec 3, 2021 | Daily Media Clips
Good Morning NUNAverse, New York officials have confirmed five cases of the Omicron COVID-19 variant in the New York City metropolitan area, Governor Kathy Hochul announced late Thursday, hours after cases were detected in Minnesota and Colorado. One case was...
by NUNAverse | Dec 2, 2021 | Daily Media Clips
Good Morning NUNAverse, The U.S. recorded its first confirmed case of the omicron variant of COVID-19 yesterday in a vaccinated traveler who returned to California after a trip to South Africa. Dr. Anthony Fauci announced the finding at the White House. The...
by NUNAverse | Dec 1, 2021 | Daily Media Clips
Good Morning NUNAverse, Advisers to the US Food and Drug Administration voted 13-10 Tuesday to recommend emergency use authorization of a pill made by Merck and Ridgeback Biotherapeutics to help treat COVID-19. Members of the FDA’s Antimicrobial Drugs...
